Clinical-Stage Platforms
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 TMO | Thermo Fisher Scientific, Inc. | $174.7b | $440.56 | +0.5% | 686.0K |
 A | Agilent Technologies Inc. | $32.5b | $112.23 | +0.5% | 490.0K |
 WAT | Waters Corp | $29.5b | $332.73 | +1.1% | 286.9K |
 IQV | IQVIA Holdings Inc. | $26.7b | $172.56 | +2.0% | 373.5K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $22.0b | $52.60 | -0.5% | 1.2M |
 WST | West Pharmaceutical Services, Inc. | $20.6b | $304.14 | +0.4% | 154.6K |
 ASND | Ascendis Pharma A/S Ordinary Share | $13.7b | $236.54 | -1.6% | 145.3K |
 MEDP | Medpace Holdings, Inc. Common Stock | $11.7b | $423.93 | +2.1% | 114.5K |
 RVTY | Revvity, Inc. | $9.5b | $95.67 | +1.8% | 176.0K |
 TECH | Bio-Techne Corp. | $8.4b | $44.49 | +2.8% | 1.6M |
 CRL | Charles River Laboratories International, Inc. | $8.2b | $154.52 | +2.4% | 760.0K |
 BIO.B | Bio-Rad Laboratories, Inc. Class B | $8.1b | $278.84 | +6.9% | 94 |
 ICLR | Icon Plc | $7.8b | $116.56 | +0.1% | 191.6K |
 HALO | Halozyme Therapeutics, Inc. | $7.6b | $67.29 | +0.3% | 557.1K |
 QGEN | QIAGEN N.V. | $7.0b | $33.40 | +1.3% | 1.1M |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $6.8b | $80.36 | -2.3% | 203.9K |
 RGEN | Repligen Corp | $6.6b | $105.19 | +2.3% | 510.7K |
 CELC | Celcuity Inc. Common Stock | $5.8b | $131.51 | -4.5% | 292.3K |
 CGON | CG Oncology, Inc. Common stock | $5.8b | $64.44 | -3.7% | 303.7K |
 BRKR | Bruker Corporation | $5.5b | $43.05 | +0.4% | 691.1K |
 AVTR | Avantor, Inc. | $5.3b | $7.69 | +1.0% | 3.5M |
 MANE | Veradermics, Incorporated | $3.8b | $100.58 | +0.9% | 148.2K |
 TWST | Twist Bioscience Corporation Common Stock | $3.6b | $49.43 | +0.5% | 451.0K |
 OGN | Organon & Co. | $3.5b | $13.43 | +0.2% | 1.3M |
 KOD | Kodiak Sciences Inc Common Stock | $2.8b | $35.53 | -4.0% | 249.5K |
 LGND | Ligand Pharmaceuticals Inc. | $2.8b | $209.47 | -1.8% | 28.7K |
 RLAY | Relay Therapeutics, Inc. Common Stock | $2.3b | $11.94 | -2.1% | 700.7K |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 TYRA | Tyra Biosciences, Inc. Common Stock | $2.1b | $35.12 | -5.2% | 291.8K |
 ZYME | Zymeworks Inc. | $2.1b | $24.23 | +1.3% | 285.5K |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $2.0b | $13.59 | -4.3% | 499.8K |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.9b | $105.91 | -2.5% | 115.0K |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $1.8b | $2.85 | -2.6% | 10.5M |
 NRIX | Nurix Therapeutics, Inc. Common stock | $1.8b | $15.96 | +0.7% | 1.2M |
 GENB | Generate Biomedicines, Inc. Common Stock | $1.6b | $13.64 | -14.7% | 862.9K |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $1.5b | $17.97 | -1.0% | 202.2K |
 HROW | Harrow, Inc. Common Stock | $1.5b | $31.17 | -0.1% | 247.5K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.4b | $19.56 | -3.3% | 200.9K |
 ABCL | AbCellera Biologics Inc. Common Shares | $1.3b | $3.96 | -3.3% | 5.4M |
 ALVO | Alvotech Ordinary Shares | $1.1b | $3.25 | -2.0% | 129.9K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.0b | $22.64 | -0.0% | 81.6K |
 FTRE | Fortrea Holdings Inc. Common Stock | $1.0b | $13.65 | -0.1% | 193.2K |
 CERT | Certara, Inc. Common Stock | $0.9b | $4.51 | +0.7% | 820.8K |
 OPK | Opko Health Inc. | $0.9b | $1.11 | +1.4% | 763.4K |
 SDGR | Schrodinger, Inc. Common Stock | $0.9b | $12.09 | +1.1% | 395.0K |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $3.00 | -2.1% | 1.2M |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $0.9b | $7.33 | +3.6% | 4.9M |
 PHAT | Phathom Pharmaceuticals, Inc. Common Stock | $0.9b | $11.83 | -0.4% | 219.4K |
 ABSI | Absci Corporation Common Stock | $0.8b | $4.92 | -4.0% | 1.2M |
 VOR | Vor Biopharma Inc. Common Stock | $0.7b | $14.19 | -3.0% | 260.2K |